ATE108833T1 - Antikörper gegen fibrin, immunogene peptide für die herstellung dieser antikörper, verfahren zur bestimmung von fibrin und pharmazeutische zubereitungen auf der basis dieser antikörper. - Google Patents
Antikörper gegen fibrin, immunogene peptide für die herstellung dieser antikörper, verfahren zur bestimmung von fibrin und pharmazeutische zubereitungen auf der basis dieser antikörper.Info
- Publication number
- ATE108833T1 ATE108833T1 AT90201065T AT90201065T ATE108833T1 AT E108833 T1 ATE108833 T1 AT E108833T1 AT 90201065 T AT90201065 T AT 90201065T AT 90201065 T AT90201065 T AT 90201065T AT E108833 T1 ATE108833 T1 AT E108833T1
- Authority
- AT
- Austria
- Prior art keywords
- antibodies
- fibrin
- determination
- production
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6845—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a cytokine, e.g. growth factors, VEGF, TNF, a lymphokine or an interferon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8901102A NL8901102A (nl) | 1989-05-01 | 1989-05-01 | Antilichamen tegen fibrine; voor de bereiding van de antilichamen geschikte immunogene peptiden, werkwijze voor het bepalen van fibrine en farmaceutisch preparaat op basis van de antilichamen. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE108833T1 true ATE108833T1 (de) | 1994-08-15 |
Family
ID=19854590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90201065T ATE108833T1 (de) | 1989-05-01 | 1990-04-26 | Antikörper gegen fibrin, immunogene peptide für die herstellung dieser antikörper, verfahren zur bestimmung von fibrin und pharmazeutische zubereitungen auf der basis dieser antikörper. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5124439A (de) |
EP (1) | EP0396188B1 (de) |
JP (1) | JP2634683B2 (de) |
AT (1) | ATE108833T1 (de) |
DE (1) | DE69010750T2 (de) |
DK (1) | DK0396188T3 (de) |
ES (1) | ES2060927T3 (de) |
NL (1) | NL8901102A (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994009034A1 (en) * | 1992-10-12 | 1994-04-28 | Agen Limited | Clot directed anticoagulant, process for making same and methods of use |
DE69435072T2 (de) * | 1993-11-02 | 2009-01-29 | Mitsubishi Kagaku Iatron, Inc. | Antikörper gegen menschliches lösliches fibrin, hybridome, die sie produzieren und immunmessverfahren |
EP0759762A4 (de) * | 1994-05-02 | 1999-09-01 | Squibb & Sons Inc | Rekombinante fibrinketten, fibrin und fibrinhomologe |
DE19729591A1 (de) * | 1997-07-10 | 1999-02-11 | Therasorb Medizinische Systeme | Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen |
US9814672B2 (en) | 2007-03-09 | 2017-11-14 | Susan T. Laing | Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4916070A (en) * | 1986-04-14 | 1990-04-10 | The General Hospital Corporation | Fibrin-specific antibodies and method of screening for the antibodies |
DE3701812A1 (de) * | 1987-01-22 | 1988-08-04 | Max Planck Gesellschaft | Fibrinspezifischer antikoerper, verfahren zur seiner herstellung und seine verwendung |
-
1989
- 1989-05-01 NL NL8901102A patent/NL8901102A/nl not_active Application Discontinuation
-
1990
- 1990-04-26 EP EP90201065A patent/EP0396188B1/de not_active Expired - Lifetime
- 1990-04-26 ES ES90201065T patent/ES2060927T3/es not_active Expired - Lifetime
- 1990-04-26 AT AT90201065T patent/ATE108833T1/de not_active IP Right Cessation
- 1990-04-26 DK DK90201065.1T patent/DK0396188T3/da active
- 1990-04-26 DE DE69010750T patent/DE69010750T2/de not_active Expired - Fee Related
- 1990-04-30 US US07/516,428 patent/US5124439A/en not_active Expired - Lifetime
- 1990-05-01 JP JP2115711A patent/JP2634683B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5124439A (en) | 1992-06-23 |
DK0396188T3 (da) | 1994-08-22 |
NL8901102A (nl) | 1990-12-03 |
DE69010750D1 (de) | 1994-08-25 |
EP0396188B1 (de) | 1994-07-20 |
ES2060927T3 (es) | 1994-12-01 |
EP0396188A1 (de) | 1990-11-07 |
JPH0348159A (ja) | 1991-03-01 |
JP2634683B2 (ja) | 1997-07-30 |
DE69010750T2 (de) | 1994-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Marder et al. | High Molecular Weight Derivatives of Human Fibrinogen Produced by Plasmin: III. THEIR NH2-TERMINAL AMINO ACIDS AND COMPARISON WITH THE “NH2-TERMINAL DISULFIDE KNOT | |
ATE92107T1 (de) | N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen. | |
DE3856265D1 (de) | Varianten des pankreatischen Rinder-Trypsininhibitors, deren Herstellung und Verwendung | |
DE3586402D1 (de) | Proteinzusammensetzung mit koagulations-wirkung und verfahren zu ihrer herstellung. | |
DE69018920D1 (de) | Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine. | |
ATE373010T1 (de) | Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen | |
ATE295414T1 (de) | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen | |
ATE232237T1 (de) | Herstellung von funktionellen, menschlichen urokinaseproteinen | |
DE69123106D1 (de) | Polypeptid, das zur Interaktion mit Thrombin fähig ist | |
ATE360695T1 (de) | Cortistatin: neuropeptide, zusammensetzungen und methoden | |
ATE108833T1 (de) | Antikörper gegen fibrin, immunogene peptide für die herstellung dieser antikörper, verfahren zur bestimmung von fibrin und pharmazeutische zubereitungen auf der basis dieser antikörper. | |
SE8902148L (sv) | Syntetiska peptid antigen foer detektion av htlv-1 infektion | |
ATE115188T1 (de) | Antikörper gegen fibrin, immunogen zur herstellung desselben, verfahren zur bestimmung von fibrin und pharmazeutisches präparat auf basis der antikörper. | |
ATE166231T1 (de) | Produktion und verwendung von antihelmintischen substanzen und schützenden immunogenen | |
DE68923496D1 (de) | Verfahren zur Herstellung von motilinähnlichen Polypeptiden und seine Expression. | |
DE59108261D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
ATE141645T1 (de) | In vitro-behandlung von fusionsproteinen | |
ATE205529T1 (de) | Reninaktive substanz enthaltend humanes prorenin und antikörper gegen das prorenin profragment | |
DE69534738D1 (de) | Leukocyten-aktivierender Faktor | |
ATE110112T1 (de) | Verfahren und systeme zur herstellung von hiv- antigenen. | |
ATE110775T1 (de) | Verfahren zur herstellung von hirudin. | |
DD133231A1 (de) | Verfahren zur herstellung von peptiden,proteinen und proteinsequenzen | |
ATE51154T1 (de) | Antithrombogenes, nichtcalcifizierendes material und ein verfahren zur herstellung von gegenstaenden fuer medizinische zwecke. | |
DE3888078D1 (de) | Veränderungsverfahren für Peptide und Proteine. | |
DE3485972D1 (de) | Antigen aktive aminosaeuresequenzen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |